# Rwanda Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Rwanda HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Rwanda (RWA)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $283.5K
- Products: 13
- Buyer markets: 17
- Average CAGR: +199.7%
- Global sector size: $108.8B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $18.6B | $15.8K | $33.1B | -19.4% | 2 | +0.0% |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $43.9B | $45.6K | $16.2B | +12.3% | 9 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $10.3B | $177.1K | $5.6B | +17.9% | 5 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $8.0B | $5.7K | $3.7B | +1423.2% | 6 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $11.5B | $14.6K | $3.4B | -28.3% | 6 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.6B | $11.0K | $3.1B | -11.0% | 6 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $4.3B | $0.2 | $1.5B | -0.0% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $3.0B | $2.1K | $1.4B | +109.7% | 3 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $3.7K | $640.9M | +0.2% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $904.7M | $15.7 | $457.0M | -14.4% | 2 | +0.0% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $1.3B | $3.1 | $397.5M | -9.0% | 1 | +0.0% |
| HS 310280 - Fertilizers, mineral or chemical: nitrogenous, mixtures of urea and ammonium nitrate in aqueous or ammoniacal solution | $499.9M | $7.5K | $253.7M | -16.6% | 1 | +0.0% |
| HS 330410 - Cosmetic and toilet preparations: lip make-up | $852.7M | $553.6 | $220.1M | +48.1% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $35.5B calculated opportunity across 7 products.
- Belgium (BEL): $8.1B calculated opportunity across 3 products.
- Canada (CAN): $6.9B calculated opportunity across 6 products.
- France (FRA): $4.7B calculated opportunity across 4 products.
- China (CHN): $4.4B calculated opportunity across 2 products.
- United Kingdom (GBR): $2.8B calculated opportunity across 4 products.
- Germany (DEU): $1.6B calculated opportunity across 2 products.
- Netherlands (NLD): $1.5B calculated opportunity across 3 products.
- United Arab Emirates (ARE): $1.4B calculated opportunity across 3 products.
- Republic of Korea (KOR): $864.1M calculated opportunity across 3 products.
- South Africa (ZAF): $677.5M calculated opportunity across 1 products.
- Sweden (SWE): $353.7M calculated opportunity across 1 products.

## Growth stars

- HS 382200: +1423.2% average CAGR, $3.7B calculated opportunity.
- HS 300212: +109.7% average CAGR, $1.4B calculated opportunity.
- HS 330410: +48.1% average CAGR, $220.1M calculated opportunity.
- HS 330300: +17.9% average CAGR, $5.6B calculated opportunity.
- HS 300490: +12.3% average CAGR, $16.2B calculated opportunity.
- HS 340600: +0.2% average CAGR, $640.9M calculated opportunity.
- HS 300215: -0.0% average CAGR, $1.5B calculated opportunity.
- HS 330590: -9.0% average CAGR, $397.5M calculated opportunity.
- HS 300290: -11.0% average CAGR, $3.1B calculated opportunity.
- HS 293499: -14.4% average CAGR, $457.0M calculated opportunity.

## Diversification opportunities

- HS 300490: 9 buyer markets, $16.2B calculated opportunity.
- HS 382200: 6 buyer markets, $3.7B calculated opportunity.
- HS 330499: 6 buyer markets, $3.4B calculated opportunity.
- HS 300290: 6 buyer markets, $3.1B calculated opportunity.
- HS 330300: 5 buyer markets, $5.6B calculated opportunity.
- HS 300212: 3 buyer markets, $1.4B calculated opportunity.
- HS 293719: 2 buyer markets, $33.1B calculated opportunity.
- HS 293499: 2 buyer markets, $457.0M calculated opportunity.
- HS 300215: 1 buyer markets, $1.5B calculated opportunity.
- HS 340600: 1 buyer markets, $640.9M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.